Recent News

Roche’s bags new US approvals for Tecentriq, Lucentis

The US Food and Drug Administration has expanded the approval of Roche’s Tecentriq so that it can be used to treat a wider range of patients with bladder cancer.

The US

Original Link...

Tags: medical, MEDICINE, pharmaceuticals
0 Volde

Read On: